Oral morphine for cancer pain
Background This is the third updated version of a Cochrane review first published in Issue 4,
2003 of The Cochrane Library and first updated in 2007. Morphine has been used for many …
2003 of The Cochrane Library and first updated in 2007. Morphine has been used for many …
Opioids for cancer pain‐an overview of Cochrane reviews
Background Pain is a common symptom with cancer, and 30% to 50% of all people with
cancer will experience moderate to severe pain that can have a major negative impact on …
cancer will experience moderate to severe pain that can have a major negative impact on …
Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative …
A Caraceni, A Pigni, C Brunelli - Palliative medicine, 2011 - journals.sagepub.com
The aim of this systematic review was to evaluate the evidence that oral morphine can be
recommended as the first choice opioid in the treatment of moderate to severe cancer pain …
recommended as the first choice opioid in the treatment of moderate to severe cancer pain …
Oxycodone for cancer‐related pain
M Schmidt-Hansen, MI Bennett… - Cochrane Database …, 2022 - cochranelibrary.com
Background Many people with cancer experience moderate to severe pain that requires
treatment with strong opioids, such as oxycodone and morphine. Strong opioids are …
treatment with strong opioids, such as oxycodone and morphine. Strong opioids are …
Oral paracetamol (acetaminophen) for cancer pain
Background Pain is a common symptom with cancer, and 30% to 50% of all people with
cancer will experience moderate to severe pain that can have a major negative impact on …
cancer will experience moderate to severe pain that can have a major negative impact on …
Tramadol with or without paracetamol (acetaminophen) for cancer pain
Background Tramadol is an opioid analgesic licensed for use in moderate to severe pain. It
is considered as a low risk for abuse, so control regulations are not as stringent as …
is considered as a low risk for abuse, so control regulations are not as stringent as …
A systematic review of randomized trials on the effectiveness of opioids for cancer pain
D Koyyalagunta, E Bruera, DR Solanki… - Pain …, 2012 - search.proquest.com
BACKGROUND: In all recommended guidelines put forth for the treatment of cancer pain,
opioids continue to be an important part of a physician's armamentarium. Though opioids …
opioids continue to be an important part of a physician's armamentarium. Though opioids …
Buprenorphine for treating cancer pain
M Schmidt‐Hansen, N Bromham… - Cochrane Database …, 2015 - cochranelibrary.com
Background Many patients with cancer experience moderate to severe pain that requires
treatment with strong analgesics. Buprenorphine, fentanyl and morphine are examples of …
treatment with strong analgesics. Buprenorphine, fentanyl and morphine are examples of …
High‐dose opioids for chronic non‐cancer pain: an overview of Cochrane Reviews
Objectives To describe the evidence from Cochrane Reviews and overviews regarding the
efficacy and safety of high‐dose opioids (defined as 200 mg morphine equivalent or more …
efficacy and safety of high‐dose opioids (defined as 200 mg morphine equivalent or more …
Methadone for cancer pain
AB Nicholson, GR Watson, S Derry… - Cochrane Database of …, 2017 - cochranelibrary.com
Background This is an updated review originally published in 2004 and first updated in
2007. This version includes substantial changes to bring it in line with current …
2007. This version includes substantial changes to bring it in line with current …